上海复星医药产业发展有限公司 Shanghai Fosun Pharmaceutical Development Co.Ltd.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Fosun Pharma Announces 2024Q3 Financial Results 2024-10-30 10:41
Fosun Pharma Announces 2024 Interim Results 2024-08-28 18:10
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa 2024-04-26 12:39
Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs 2023-12-14 17:00
Fosun Pharma Announces 2023 Interim Results: Continues to Promote Innovation Transformation and Optimizes Product Structure 2023-08-30 10:53
Fosun Pharma Participates in 2023 BIO International Convention to Demonstrate its Global Innovation Capabilities 2023-06-06 22:15
Fosun Pharma and IFC Partner to Improve Access to High Quality Medicines in Africa 2023-06-06 19:52
Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements 2023-05-10 22:57
Fosun Pharma Develops Innovative Artemisinin-based Antimalarial Drugs Contributing to the Efforts for A Malaria-free World Through the Belt and Road Initiative 2023-04-26 22:32
Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public 2023-03-29 14:06
Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement 2023-03-28 16:20
Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US 2023-01-07 17:29
Comirnaty Bivalent Vaccine Arrives in Hong Kong SAR and Macau SAR and Will Soon Be Available to the Local Residents 2022-11-28 22:59
Fosun Pharma's MSCI ESG Rating Upgraded to A 2022-10-14 08:26
Fosun Pharma and MAIA Pharmaceuticals Jointly Announce the Successful Commercialization of Only FDA Approved 20ml Sodium Phenylacetate and Sodium Benzoate (SPSB) Liquid Product 2022-09-26 22:13
Fosun Pharma Announces 2022 Interim Results 2022-08-30 20:28
World Malaria Day: Fosun Pharma's Self-Developed Artemisinin Series Become Symbol of China's Innovative Medicines 2022-04-25 17:00
Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control 2022-04-14 19:45
Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively 2022-03-23 06:53
Fosun Pharma Announces 2020 Annual Results 2021-03-30 00:38
1 2